These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34108479)

  • 41. Insight into DNA substrate specificity of PARP1-catalysed DNA poly(ADP-ribosyl)ation.
    Matta E; Kiribayeva A; Khassenov B; Matkarimov BT; Ishchenko AA
    Sci Rep; 2020 Feb; 10(1):3699. PubMed ID: 32111879
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of PARP2 in DNA repair].
    Kutuzov MM; Khodyreva SN; Schreiber V; Lavrik OI
    Mol Biol (Mosk); 2014; 48(4):561-72. PubMed ID: 25842842
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of PARP1/2 and the tankyrases: emerging parallels.
    Jessop M; Broadway BJ; Miller K; Guettler S
    Biochem J; 2024 Sep; 481(17):1097-1123. PubMed ID: 39178157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain.
    Dawicki-McKenna JM; Langelier MF; DeNizio JE; Riccio AA; Cao CD; Karch KR; McCauley M; Steffen JD; Black BE; Pascal JM
    Mol Cell; 2015 Dec; 60(5):755-768. PubMed ID: 26626480
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HPF1-dependent histone ADP-ribosylation triggers chromatin relaxation to promote the recruitment of repair factors at sites of DNA damage.
    Smith R; Zentout S; Rother M; Bigot N; Chapuis C; Mihuț A; Zobel FF; Ahel I; van Attikum H; Timinszky G; Huet S
    Nat Struct Mol Biol; 2023 May; 30(5):678-691. PubMed ID: 37106138
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The CSB chromatin remodeler regulates PARP1- and PARP2-mediated single-strand break repair at actively transcribed DNA regions.
    Bilkis R; Lake RJ; Cooper KL; Tomkinson A; Fan HY
    Nucleic Acids Res; 2023 Aug; 51(14):7342-7356. PubMed ID: 37326017
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP.
    Frigon L; Pascal JM
    Nucleic Acids Res; 2023 Dec; 51(22):12492-12507. PubMed ID: 37971310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Structure of ADP-ribosylating enzyme and DNA repair].
    Uchida K
    Nihon Rinsho; 1993 Nov; 51(11):3051-61. PubMed ID: 8277589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progress and outlook in studying the substrate specificities of PARPs and related enzymes.
    Suskiewicz MJ; Palazzo L; Hughes R; Ahel I
    FEBS J; 2021 Apr; 288(7):2131-2142. PubMed ID: 32785980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Poly(ADP-ribose) polymerase 1 regulates mitochondrial DNA repair in an NAD-dependent manner.
    Herrmann GK; Russell WK; Garg NJ; Yin YW
    J Biol Chem; 2021; 296():100309. PubMed ID: 33482196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs.
    Rudolph J; Roberts G; Luger K
    Nat Commun; 2021 Feb; 12(1):736. PubMed ID: 33531508
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks.
    Blessing C; Mandemaker IK; Gonzalez-Leal C; Preisser J; Schomburg A; Ladurner AG
    Mol Cell; 2020 Dec; 80(5):862-875.e6. PubMed ID: 33275888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Poly(ADP-ribosyl)ation as a new posttranslational modification of YB-1.
    Alemasova EE; Pestryakov PE; Sukhanova MV; Kretov DA; Moor NA; Curmi PA; Ovchinnikov LP; Lavrik OI
    Biochimie; 2015 Dec; 119():36-44. PubMed ID: 26453809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. PARP1 and PARP2 stabilise replication forks at base excision repair intermediates through Fbh1-dependent Rad51 regulation.
    Ronson GE; Piberger AL; Higgs MR; Olsen AL; Stewart GS; McHugh PJ; Petermann E; Lakin ND
    Nat Commun; 2018 Feb; 9(1):746. PubMed ID: 29467415
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1.
    Lehmann LC; Hewitt G; Aibara S; Leitner A; Marklund E; Maslen SL; Maturi V; Chen Y; van der Spoel D; Skehel JM; Moustakas A; Boulton SJ; Deindl S
    Mol Cell; 2017 Dec; 68(5):847-859.e7. PubMed ID: 29220652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stimulation of the DNA-dependent protein kinase by poly(ADP-ribose) polymerase.
    Ruscetti T; Lehnert BE; Halbrook J; Le Trong H; Hoekstra MF; Chen DJ; Peterson SR
    J Biol Chem; 1998 Jun; 273(23):14461-7. PubMed ID: 9603959
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inactive Parp2 causes Tp53-dependent lethal anemia by blocking replication-associated nick ligation in erythroblasts.
    Lin X; Gupta D; Vaitsiankova A; Bhandari SK; Leung KSK; Menolfi D; Lee BJ; Russell HR; Gershik S; Huang X; Gu W; McKinnon PJ; Dantzer F; Rothenberg E; Tomkinson AE; Zha S
    Mol Cell; 2024 Oct; 84(20):3916-3931.e7. PubMed ID: 39383878
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel inhibitors of poly(ADP-ribose) polymerase/PARP1 and PARP2 identified using a cell-based screen in yeast.
    Perkins E; Sun D; Nguyen A; Tulac S; Francesco M; Tavana H; Nguyen H; Tugendreich S; Barthmaier P; Couto J; Yeh E; Thode S; Jarnagin K; Jain A; Morgans D; Melese T
    Cancer Res; 2001 May; 61(10):4175-83. PubMed ID: 11358842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human apurinic/apyrimidinic endonuclease 1 is modified in vitro by poly(ADP-ribose) polymerase 1 under control of the structure of damaged DNA.
    Moor NA; Vasil'eva IA; Kuznetsov NA; Lavrik OI
    Biochimie; 2020 Jan; 168():144-155. PubMed ID: 31668992
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Crystal structure of the catalytic domain of human PARP2 in complex with PARP inhibitor ABT-888.
    Karlberg T; Hammarström M; Schütz P; Svensson L; Schüler H
    Biochemistry; 2010 Feb; 49(6):1056-8. PubMed ID: 20092359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.